Featured Research

from universities, journals, and other organizations

The future of cancer research: In your medicine cabinet?

Date:
July 10, 2014
Source:
ecancer
Summary:
Where are the new low-cost cancer drugs? Do common drugs from the pharmacy represent the future of cancer treatment? Existing and widely-used non-cancer drugs may represent a relatively untapped source of novel therapies for cancer, new research suggests.

Where are the new low-cost cancer drugs? Do common drugs from the pharmacy represent the future of cancer treatment? The Repurposing Drugs in Oncology (ReDO) project, an international collaboration between Anticancer Fund, Belgium, and US based GlobalCures, finds that existing and widely-used non-cancer drugs may represent a relatively untapped source of novel therapies for cancer.

Currently the main focus in new drug development is on targeted therapies aimed at specific cancer pathways. In spite of major advances, the side-effects and modest effectiveness of such therapies raise concerns; additionally the high cost of these new therapies puts them out of reach for many patients. In contrast, there is strong evidence that some common inexpensive drugs used in the treatment of other diseases (e.g. diabetes, high blood pressure), have anti-cancer effects that can be exploited in combination treatments.

"It really is a case of looking at the cancer treatments in our medicine cabinets," says Pan Pantziarka, lead author of the first two papers to be published by the ReDO project.

Working in the US, Belgium and the UK the ReDO team have drawn up a short-list of drugs with enough evidence to go to clinical trial. Working with leading oncology journal ecancermedicalscience, ReDO is producing a series of scientific papers that explore these drugs in detail -- starting with the drug mebendazole, an over-the-counter treatment currently used for threadworm. The paper cites strong pre-clinical evidence that mebendazole has anti-cancer properties, particularly in colorectal cancer, brain tumours, melanoma and possibly leukemia and bone cancer. The authors conclude that there is sufficient evidence to begin clinical trials now.

"Such promising therapies are often ignored since pharmaceutical companies lack financial incentives to develop them further via proper clinical trials," says Gauthier Bouche, medical director of Anticancer Fund. "The ReDO project was established to find and document such opportunities."

In addition to mebendazole, other high-priority cancer drug candidates include cimetidine (an antacid), nitroglycerin (used to treat angina), itraconazole (a common anti-fungal), diclofenac (an over-the-counter pain killer) and clarithromycin (an antibiotic).

"ecancer is committed to developing affordable cancer care in all emerging countries," says Professor Gordon McVie, of the European Institute of Oncology and ecancer. "We have great pleasure therefore in partnering ReDO in disseminating news from their important and innovative project. A success with even one of their repurposed drugs would have a significant impact on improving cancer care in India, Africa or South America, as well as in the developed world."

However, without industry funding getting these low-cost and relatively non-toxic drugs to trial is a challenge for society. Dr. Vikas P. Sukhatme, co-founder of GlobalCures and professor at Harvard Medical School, describes these drugs as "financial orphans looking for adoption."

"Repurposing these drugs will save money and lives," says Pan Pantziarka. "This isn't just about medical breakthroughs; it's about social necessity worldwide."


Story Source:

The above story is based on materials provided by ecancer. Note: Materials may be edited for content and length.


Journal References:

  1. Pan Pantziarka, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme and Vikas P. Sukhatme. Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent. Ecancermedicalscience, 2014 DOI: 10.3332/ecancer.2014.443
  2. Pan Pantziarka, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, Vikas P. Sukhatme. The Repurposing Drugs in Oncology (ReDO) Project. Ecancermedicalscience, 2014 DOI: 10.3332/ecancer.2014.442

Cite This Page:

ecancer. "The future of cancer research: In your medicine cabinet?." ScienceDaily. ScienceDaily, 10 July 2014. <www.sciencedaily.com/releases/2014/07/140710081204.htm>.
ecancer. (2014, July 10). The future of cancer research: In your medicine cabinet?. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2014/07/140710081204.htm
ecancer. "The future of cancer research: In your medicine cabinet?." ScienceDaily. www.sciencedaily.com/releases/2014/07/140710081204.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com
Google's Next Frontier: The Human Body

Google's Next Frontier: The Human Body

Newsy (July 27, 2014) Google is collecting genetic and molecular information to paint a picture of the perfectly healthy human. Video provided by Newsy
Powered by NewsLook.com
What's To Blame For Worst Ebola Outbreak In History?

What's To Blame For Worst Ebola Outbreak In History?

Newsy (July 27, 2014) A U.S. doctor has tested positive for the deadly Ebola virus, as the worst-ever outbreak continues to grow. Video provided by Newsy
Powered by NewsLook.com
Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins